ARCHIVES

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

With $10.4 Billion To Spend In 18 Months, NIH Says Money Will Be Spent Rationally. Funds Will Support R01s

February 20, 2009

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

Obituary: Rajka Medenica, controversial Physician

December 5, 1997

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974